A future where every African can enjoy a life of better health and well-being is our goal.
The research aims to collect data that can help set industry benchmarks in various areas. R&D may be helpful in many cases, such as:
Advance the understanding of the chemicals already present in different strains of cannabis and the therapeutic properties of cannabis for health conditions, as well as the potential effects of accumulated exposure over time.
Optimise production processes to improve yields and minimise costs.
Create new and innovative products that will better meet consumers’ needs and develop safer dosing methods for more precise ingestion of cannabis.
Sufficient research may give more confidence to physicians on cannabis safety and efficacy and impact the number of prescriptions that patients receive.
Cannabis innovation may drive new approaches in the extraction processes, allowing a higher and more precise yield of raw material.
Research into cannabis benefits for other health conditions yet to be explored.
To gain market share with innovative cannabis products.
To be recognized and accepted by regulatory agencies such as Health Canada, the Food and Drug Administration, and the European Medicines Agency.
Controlled Class A, Substances in Research - overview